Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2008 1
2009 2
2011 3
2012 3
2018 1
2019 1
2020 1
2021 3
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP).
Herrera C, Lwanga J, Lee M, Mantori S, Amara A, Else L, Penchala SD, Egan D, Challenger E, Dickinson L, Boffito M, Shattock R, Khoo S, Fox J. Herrera C, et al. Among authors: lwanga j. J Antimicrob Chemother. 2021 Jul 15;76(8):2129-2136. doi: 10.1093/jac/dkab136. J Antimicrob Chemother. 2021. PMID: 33993302 Free PMC article. Clinical Trial.
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.
Thornhill JP, Fox J, Martin GE, Hall R, Lwanga J, Lewis H, Brown H, Robinson N, Kuldanek K, Kinloch S, Nwokolo N, Whitlock G, Fidler S, Frater J. Thornhill JP, et al. Among authors: lwanga j. AIDS. 2024 Apr 1;38(5):679-688. doi: 10.1097/QAD.0000000000003825. Epub 2023 Dec 21. AIDS. 2024. PMID: 38133660
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.
Pace M, Ogbe A, Hurst J, Robinson N, Meyerowitz J, Olejniczak N, Thornhill JP, Jones M, Waters A, Lwanga J, Kuldanek K, Hall R, Zacharopoulou P, Martin GE, Brown H, Nwokolo N, Peppa D, Fox J, Fidler S, Frater J. Pace M, et al. Among authors: lwanga j. Front Immunol. 2022 Aug 30;13:878743. doi: 10.3389/fimmu.2022.878743. eCollection 2022. Front Immunol. 2022. PMID: 36110857 Free PMC article.
Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study).
Lee MJ, Snell LB, Douthwaite ST, Fidler S, Fitzgerald N, Goodwin L, Hamzah L, Kulasegaram R, Lawrence S, Lwanga J, Marchant R, Orkin C, Palfreeman A, Parthasarathi P, Pareek M, Ring K, Sharaf H, Shekarchi-Khanghahi E, Simons R, Teh JJ, Thornhill J, van Halsema C, Williamson M, Wiselka M, Nori A, Fox J, Smith C. Lee MJ, et al. Among authors: lwanga j. HIV Med. 2022 Feb;23(2):121-133. doi: 10.1111/hiv.13174. Epub 2021 Sep 23. HIV Med. 2022. PMID: 34555242 Free PMC article.
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.
Martin GE, Pace M, Thornhill JP, Phetsouphanh C, Meyerowitz J, Gossez M, Brown H, Olejniczak N, Lwanga J, Ramjee G, Kaleebu P, Porter K, Willberg CB, Klenerman P, Nwokolo N, Fox J, Fidler S, Frater J. Martin GE, et al. Among authors: lwanga j. Front Immunol. 2018 May 4;9:928. doi: 10.3389/fimmu.2018.00928. eCollection 2018. Front Immunol. 2018. PMID: 29780387 Free PMC article.
Averting biodiversity collapse in tropical forest protected areas.
Laurance WF, Useche DC, Rendeiro J, Kalka M, Bradshaw CJ, Sloan SP, Laurance SG, Campbell M, Abernethy K, Alvarez P, Arroyo-Rodriguez V, Ashton P, Benítez-Malvido J, Blom A, Bobo KS, Cannon CH, Cao M, Carroll R, Chapman C, Coates R, Cords M, Danielsen F, De Dijn B, Dinerstein E, Donnelly MA, Edwards D, Edwards F, Farwig N, Fashing P, Forget PM, Foster M, Gale G, Harris D, Harrison R, Hart J, Karpanty S, Kress WJ, Krishnaswamy J, Logsdon W, Lovett J, Magnusson W, Maisels F, Marshall AR, McClearn D, Mudappa D, Nielsen MR, Pearson R, Pitman N, van der Ploeg J, Plumptre A, Poulsen J, Quesada M, Rainey H, Robinson D, Roetgers C, Rovero F, Scatena F, Schulze C, Sheil D, Struhsaker T, Terborgh J, Thomas D, Timm R, Urbina-Cardona JN, Vasudevan K, Wright SJ, Arias-G JC, Arroyo L, Ashton M, Auzel P, Babaasa D, Babweteera F, Baker P, Banki O, Bass M, Bila-Isia I, Blake S, Brockelman W, Brokaw N, Brühl CA, Bunyavejchewin S, Chao JT, Chave J, Chellam R, Clark CJ, Clavijo J, Congdon R, Corlett R, Dattaraja HS, Dave C, Davies G, Beisiegel Bde M, da Silva Rde N, Di Fiore A, Diesmos A, Dirzo R, Doran-Sheehy D, Eaton M, Emmons L, Estrada A, Ewango C, Fedigan L, Feer F, Fruth B, Willis JG, Goodale U… See abstract for full author list ➔ Laurance WF, et al. Among authors: lwanga j. Nature. 2012 Sep 13;489(7415):290-4. doi: 10.1038/nature11318. Nature. 2012. PMID: 22832582 Free article.
Feasibility randomized-controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN study.
Scott W, Guildford BJ, Badenoch J, Driscoll E, Chilcot J, Norton S, Kemp HI, Lee MJ, Lwanga J, Boffito M, Moyle G, Post FA, Campbell L, Josh J, Clift P, C de C Williams A, Rice AS, McCracken LM. Scott W, et al. Among authors: lwanga j. Eur J Pain. 2021 Aug;25(7):1493-1507. doi: 10.1002/ejp.1762. Epub 2021 Mar 26. Eur J Pain. 2021. PMID: 33711209 Clinical Trial.
19 results